Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-277564
Filing Date
2025-11-12
Accepted
2025-11-12 16:09:02
Documents
80
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20250930.htm   iXBRL 10-Q 3036893
2 EX-31.1 lyra-ex31_1.htm EX-31.1 17979
3 EX-31.2 lyra-ex31_2.htm EX-31.2 17973
4 EX-32.1 lyra-ex32_1.htm EX-32.1 10351
5 EX-32.2 lyra-ex32_2.htm EX-32.2 10340
  Complete submission text file 0001193125-25-277564.txt   11058175

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20250930.xsd EX-101.SCH 1416206
83 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20250930_htm.xml XML 1950214
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 251472747
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)